Nov 12, 2025 • Motley Fool
SOMEWHAT-BULLISH
2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon
If you have decades of investing runway left, consider these two top healthcare stocks.
Oct 30, 2025 • Zacks Commentary
NEUTRAL
NovoCure ( NVCR ) Reports Q3 Loss, Tops Revenue Estimates
NovoCure (NVCR) delivered earnings and revenue surprises of +21.43% and +5.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 29, 2025 • Motley Fool
NEUTRAL
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
Investment bank analysts up and down Wall Street are pounding the table on these stocks.
Aug 22, 2025 • Zacks Commentary
NEUTRAL
NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer
NovoCure submits a PMA to the FDA for TTFields therapy in pancreatic cancer, aiming to expand its oncology reach.
Jul 28, 2025 • Benzinga
SOMEWHAT-BULLISH
Top 3 Health Care Stocks That May Explode In July - HCA Healthcare ( NYSE:HCA ) , Molina Healthcare ( NYSE:MOH )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
Jul 24, 2025 • Motley Fool
NEUTRAL
NovoCure Q2 Revenue Jumps 6 Percent
NovoCure ( NASDAQ:NVCR ) , the oncology device firm advancing Tumor Treating Fields therapy, released its second quarter 2025 results on July 24, 2025. GAAP revenue totaled $158.8 million in Q2 2025, an increase of 6% year over year and surpassing the $154.16 million analyst consensus ( GAAP ) .